Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
7 Cards in this Set
- Front
- Back
|
Anticoagulants (vein thrombosis)
Name 6 |
Heparin
Warfarin Fontaparinux Lepirudin Argatroban Desirudin |
|
|
Antiplatelets (artery thrombosis)
Name 8 |
Asprin
(adenosine diphosphate receptor antagonists) Ticlopidine Clopidogrel (glycoprotein receptor antagonists) Eptifibatide Tirofiban Abciximab Dipydamole Cilostazol |
|
|
Thrombolytics
Name 5 |
Streptokinase
Urokinase Reteplase Alteplase Temelteplase |
|
|
Hematopoetic Growth Factors
MOA Name 3 Adverse events |
Stimulate production of platelets
Erythropoietic Growth Factors Epoetin Alfa Darbepoetin Hypertension, cardiovascular events |
|
|
Leukopoietic Growth Factors
MOA Name 3 Adverse effects |
Stimulate production of leukocytes, administer SQ or IV
Filgrastim Pegfilgrastim Sargramostim Bone pain (25% of patients) Leukocytosis at high dosages |
|
|
Thrombopoetic Growth Factors
MOA Name 2 |
Stimulate platelet production in patients undergoing chemo for non-myeloid cancers--given SQ
Oprelvekin Interleukin Adverse--fluid retention, conjunctivitis, blurred vision, sudden death |
|
|
Low Molecular Weight Heparins
Benfits/Drawbacks Name 3 |
Higher bioavailability and longer 1/2 life than UFH. Do not require aPTT monitoring. Drawback: $$
Enoxaparan Dalteparin Tinzaparan |
